Reuters logo
BRIEF-Camurus AB says FDA advisory committee recommends approval of CAM2038 for treatment of opioid use disorder​
November 1, 2017 / 9:23 PM / 20 days ago

BRIEF-Camurus AB says FDA advisory committee recommends approval of CAM2038 for treatment of opioid use disorder​

Nov 1 (Reuters) - Camurus AB -

* ‍Camurus announces that FDA advisory committee recommends approval of CAM2038 for treatment of opioid use disorder​

* FDA’s Psychopharmacologic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee jointly voted 17-3 for approval of CAM2038​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below